Does preincubation with prostaglandin e1 or prostaglandin e2 enhance oxytocin-induced myometrial contractility in vitro?

Giuseppe Chiossi, Luckey C. Reed, Maged Costantine, Gary Hankins, George Saade, Monica Longo

Research output: Contribution to journalArticle

Abstract

Objective To determine if preincubation with prostaglandin E1 (PGE1) and E2 (PGE2) enhances oxytocin-induced myometrial contractility in vitro. Study Design Myometrial strips from 13 women were incubated with PGE1 (10-5 mol/L or 10-6 mol/L), PGE2 (10-5 mol/L or 10-6 mol/L) or solvent before adding cumulative concentrations of oxytocin (10 -10 to 10-6 mol/L). The area under the contraction curve was calculated after addition of each agent. One- and two-way analysis of variance was used for comparison (significance p < 0.05). Results PGE2 10-5 mol/L reduced response to oxytocin 10-9 to 10 -6 mol/L (p < 0.05). PGE2 reduced spontaneous myometrial contractility as compared with PGE1 (p < 0.05). A dose-dependent negative effect of prostaglandins was detected on oxytocin 10-8 mol/L (10 -5 mol/L > 10-6 mol/L; p < 0.05). Conclusion Contrary to the hypothesis, neither PGE1 nor PGE2 enhanced oxytocin-induced myometrial contractility; in fact, PGE2 decreased contractility.

Original languageEnglish (US)
Pages (from-to)649-654
Number of pages6
JournalAmerican Journal of Perinatology
Volume30
Issue number8
DOIs
StatePublished - 2013

Fingerprint

Alprostadil
Oxytocin
Dinoprostone
Area Under Curve
In Vitro Techniques
Analysis of Variance

Keywords

  • organ chamber
  • oxytocin
  • prostaglandin E1
  • prostaglandin E2
  • uterine contractility

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Cite this

Does preincubation with prostaglandin e1 or prostaglandin e2 enhance oxytocin-induced myometrial contractility in vitro? / Chiossi, Giuseppe; Reed, Luckey C.; Costantine, Maged; Hankins, Gary; Saade, George; Longo, Monica.

In: American Journal of Perinatology, Vol. 30, No. 8, 2013, p. 649-654.

Research output: Contribution to journalArticle

Chiossi, Giuseppe ; Reed, Luckey C. ; Costantine, Maged ; Hankins, Gary ; Saade, George ; Longo, Monica. / Does preincubation with prostaglandin e1 or prostaglandin e2 enhance oxytocin-induced myometrial contractility in vitro?. In: American Journal of Perinatology. 2013 ; Vol. 30, No. 8. pp. 649-654.
@article{275b9a60220f49e28bb8035cf91fd4cc,
title = "Does preincubation with prostaglandin e1 or prostaglandin e2 enhance oxytocin-induced myometrial contractility in vitro?",
abstract = "Objective To determine if preincubation with prostaglandin E1 (PGE1) and E2 (PGE2) enhances oxytocin-induced myometrial contractility in vitro. Study Design Myometrial strips from 13 women were incubated with PGE1 (10-5 mol/L or 10-6 mol/L), PGE2 (10-5 mol/L or 10-6 mol/L) or solvent before adding cumulative concentrations of oxytocin (10 -10 to 10-6 mol/L). The area under the contraction curve was calculated after addition of each agent. One- and two-way analysis of variance was used for comparison (significance p < 0.05). Results PGE2 10-5 mol/L reduced response to oxytocin 10-9 to 10 -6 mol/L (p < 0.05). PGE2 reduced spontaneous myometrial contractility as compared with PGE1 (p < 0.05). A dose-dependent negative effect of prostaglandins was detected on oxytocin 10-8 mol/L (10 -5 mol/L > 10-6 mol/L; p < 0.05). Conclusion Contrary to the hypothesis, neither PGE1 nor PGE2 enhanced oxytocin-induced myometrial contractility; in fact, PGE2 decreased contractility.",
keywords = "organ chamber, oxytocin, prostaglandin E1, prostaglandin E2, uterine contractility",
author = "Giuseppe Chiossi and Reed, {Luckey C.} and Maged Costantine and Gary Hankins and George Saade and Monica Longo",
year = "2013",
doi = "10.1055/s-0032-1329696",
language = "English (US)",
volume = "30",
pages = "649--654",
journal = "American Journal of Perinatology",
issn = "0735-1631",
publisher = "Thieme Medical Publishers",
number = "8",

}

TY - JOUR

T1 - Does preincubation with prostaglandin e1 or prostaglandin e2 enhance oxytocin-induced myometrial contractility in vitro?

AU - Chiossi, Giuseppe

AU - Reed, Luckey C.

AU - Costantine, Maged

AU - Hankins, Gary

AU - Saade, George

AU - Longo, Monica

PY - 2013

Y1 - 2013

N2 - Objective To determine if preincubation with prostaglandin E1 (PGE1) and E2 (PGE2) enhances oxytocin-induced myometrial contractility in vitro. Study Design Myometrial strips from 13 women were incubated with PGE1 (10-5 mol/L or 10-6 mol/L), PGE2 (10-5 mol/L or 10-6 mol/L) or solvent before adding cumulative concentrations of oxytocin (10 -10 to 10-6 mol/L). The area under the contraction curve was calculated after addition of each agent. One- and two-way analysis of variance was used for comparison (significance p < 0.05). Results PGE2 10-5 mol/L reduced response to oxytocin 10-9 to 10 -6 mol/L (p < 0.05). PGE2 reduced spontaneous myometrial contractility as compared with PGE1 (p < 0.05). A dose-dependent negative effect of prostaglandins was detected on oxytocin 10-8 mol/L (10 -5 mol/L > 10-6 mol/L; p < 0.05). Conclusion Contrary to the hypothesis, neither PGE1 nor PGE2 enhanced oxytocin-induced myometrial contractility; in fact, PGE2 decreased contractility.

AB - Objective To determine if preincubation with prostaglandin E1 (PGE1) and E2 (PGE2) enhances oxytocin-induced myometrial contractility in vitro. Study Design Myometrial strips from 13 women were incubated with PGE1 (10-5 mol/L or 10-6 mol/L), PGE2 (10-5 mol/L or 10-6 mol/L) or solvent before adding cumulative concentrations of oxytocin (10 -10 to 10-6 mol/L). The area under the contraction curve was calculated after addition of each agent. One- and two-way analysis of variance was used for comparison (significance p < 0.05). Results PGE2 10-5 mol/L reduced response to oxytocin 10-9 to 10 -6 mol/L (p < 0.05). PGE2 reduced spontaneous myometrial contractility as compared with PGE1 (p < 0.05). A dose-dependent negative effect of prostaglandins was detected on oxytocin 10-8 mol/L (10 -5 mol/L > 10-6 mol/L; p < 0.05). Conclusion Contrary to the hypothesis, neither PGE1 nor PGE2 enhanced oxytocin-induced myometrial contractility; in fact, PGE2 decreased contractility.

KW - organ chamber

KW - oxytocin

KW - prostaglandin E1

KW - prostaglandin E2

KW - uterine contractility

UR - http://www.scopus.com/inward/record.url?scp=84883134768&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883134768&partnerID=8YFLogxK

U2 - 10.1055/s-0032-1329696

DO - 10.1055/s-0032-1329696

M3 - Article

VL - 30

SP - 649

EP - 654

JO - American Journal of Perinatology

JF - American Journal of Perinatology

SN - 0735-1631

IS - 8

ER -